Cargando…
Pseudophakic macular edema in nondiabetic and diabetic patients without diabetic retinopathy treated with intravitreal dexamethasone implant
BACKGROUND: The purpose of this study was to compare the impact of intravitreal dexamethasone (DEX) implant during a 12-month period in nondiabetic and diabetic patients without diabetic retinopathy (DR) as a treatment for refractory pseudophakic cystoid macular edema (PCME) following prior treatmen...
Autores principales: | Rodrigues, Magna Vanessa, Garcia, Jose Mauricio Botto, Pacheco, Katia Delalibera, Borges, Fabricio Tadeu, Isaac, David Leonardo Cruvinel, Avila, Marcos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506302/ https://www.ncbi.nlm.nih.gov/pubmed/37723594 http://dx.doi.org/10.1186/s40942-023-00489-2 |
Ejemplares similares
-
Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients
por: Dang, Yalong, et al.
Publicado: (2014) -
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
por: Obis, Javier, et al.
Publicado: (2021) -
Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema
por: Altintas, Ayse Gul Kocak, et al.
Publicado: (2019) -
Evaluation of Predictive Factors for Successful Intravitreal Dexamethasone in Pseudophakic Cystoid Macular Edema
por: Kakkassery, Vinodh, et al.
Publicado: (2017) -
Comparison of Anatomical and Functional Outcomes of Intravitreal Dexamethasone Implant between Phakic and Pseudophakic Eyes with Diabetic Macular Edema
por: Kaldırım, Havva, et al.
Publicado: (2020)